Theodore R. Schroeder, President, CEO at CADENCE PHARMACEUTICALS INC (CADX), bought 16,000 shares at $7.48 ($120K) on 2011-05-17, disclosed to the SEC on 2011-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NBRV | BUY | 2019-08-28 | $90K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |
| CADX | SELL | 2010-07-01 | $350K | — | Filing → |